Binkow & Goldberg LLP announces that it is investigating
potential claims on behalf of investors of Aeterna
Zentaris, Inc. (“Aeterna Zentaris” or the “Company”)
(NASDAQ:AEZS) concerning possible violations of federal securities laws.
Third-Quarter 2014 Financial Highlights - Third-quarter revenues of $27.6 million, up 14.3% year-over-year; year-to-date revenue up by 57.9% - Quarterly Gross Margin at 39.4%, as compared to 39.5% year over year, and 37.8% quarter over quarter
- Quarterly Non-GAAP net income of $3.5 million, up 75.4% year over year - Non-GAAP diluted EPS at $0.12 per ADS reported for the quarter, up 100% year over year -Year-to-date Non-GAAP net income of $3.0 million, non-GAAP diluted EPS at $0.11 per ADS BEIJING , Nov.
The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the Board of
Directors of Aviv REIT, Inc. (“Aviv” or the “Company”) (NYSE: AVIV)
relating to the proposed buyout of the Company by Omega Healthcare
Investors, Inc. (“Omega”).
On October 31, 2014, Aviv and Omega announced the signing of a
definitive agreement pursuant to which Omega will acquire Aviv in a
transaction valued at approximately $3 billion.
Sign-up for - SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Aviv REIT, Inc. And Encourages Investors To Contact The Firm For Additional Information investment picks
By Barbara Kollmeyer, MarketWatch
MADRID (MarketWatch) -- Stock futures pointed to a slightly higher start for Wall Street on Monday as oil prices rose and investors focused on whether the S&P 500 and Dow industrials can maintain recent record highs.
SARASOTA, FL and WOODLAND PARK, CO --
Tecnoglass, Inc. (NASDAQ: TGLS; OTCBB: TGLSW) (“Tecnoglass” or the
“Company”), a leading manufacturer of architectural glass, windows,
and associated aluminum products for the global residential and
commercial construction industries, today announced that it will issue
its financial results for the third quarter and nine months ended
September 30, 2014 after the close of market on Tuesday, November 11,
-Halozyme completes corporate strategy review and affirms priority focus on advancing PEGPH20 and ENHANZE™- -New patient enrollment underway in Study 202 with 25 patients enrolled and more than 40 clinical sites with IRB approval-
-Royalty revenues of $2.9M, up 71% from the prior quarter- -Launch of HYQVIA® underway in the U.S.- -Second target disclosed in Pfizer collaboration- SAN DIEGO , Nov.
Horton, Inc. (NYSE:DHI), America’s Builder, announced that the
Company will make a presentation to the investment community via webcast
at the UBS Building and Building Products Annual CEO Conference on
Thursday, November 13, 2014 at 11:45 a.m. Eastern time.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.